1.Goodman, S. Osteoarthritis. In Expert Guide to Rheumatology, Yee, A., Paget, S., Eds.; American College of Physicians: Philadelphia, PA, USA, 2005; pp. 269–283.
2. Bansal, H.; Leon, J.; Pont, J.L.; Wilson, D.A.; Bansal, A.; Agarwal, D.; Preoteasa, I. Platelet-rich plasma (PRP) in osteoarthritis (OA) knee: Correct dose critical for long term clinical efficacy. Sci. Rep. 2021, 11, Art. No: 3971. DOI: 10.1038/s41598-021-83025-2. Erratum in: Sci. Rep. 2021, 11, Art. No: 18612.
3. DiCesare, P.E.; Abramson, S.; Samuels, J. Pathogenesis of osteoarthritis. In Kelley's Textbook of Rheumatology, 8th ed.; Firestein, G.S.; Kelley, W.N., Eds.; Saunders Elsevier: Philadelphia, PA, USA, 2009; pp.1685-1704.
4. Cook, C.S.; Smith, P.A. Clinical Update: Why PRP Should Be Your First Choice for Injection Therapy in Treating Osteoarthritis of the Knee. Curr. Rev. Musculoskelet. Med. 2018, 11, 583-592. DOI: 10.1007/s12178-018-9524-x.
5. Manek, N.J.; Lane, N.E. Osteoarthritis: current concepts in diagnosis and management. Am. Fam. Physician. 2000, 61, 1795-1804.
6. Sinusas, K. Osteoarthritis: diagnosis and treatment. Am. Fam. Physician. 2012, 85, 49-56. Erratum in: Am. Fam. Physician. 2012, 86, 893.
7. Emami, A.; Tepper, J.; Short, B.; Yaksh, T.L.; Bendele, A.M.; Ramani, T.; Cisternas, A.F.; Chang, J.H.; Mellon, R.D. Toxicology Evaluation of Drugs Administered via Uncommon Routes: Intranasal, Intraocular, Intrathecal/Intraspinal, and Intra-Articular. Int. J. Toxicol. 2018, 37, 4–27. DOI: 10.1177/1091581817741840.
8. Testa, G.; Giardina, S.M.C.; Culmone, A.; Vescio, A.; Turchetta, M.; Cannavò, S.; Pavone, V. Intra-Articular Injections in Knee Osteoarthritis: A Review of Literature. J. Funct. Morphol. Kinesiol. 2021, 6, Art. No: 15. DOI: 10.3390/jfmk6010015.
9. Jones, I.A.; Togashi, R.; Wilson, M.L.; Heckmann, N.; Vangsness, C.T. Jr. Intra-articular treatment options for knee osteoarthritis. Nat. Rev. Rheumatol. 2019, 15, 77-90. DOI: 10.1038/s41584-018-0123-4.
10. El-Kadiry, A.E.; Lumbao, C.; Salame, N.; Rafei, M.; Shammaa, R. Bone marrow aspirate concentrate versus platelet-rich plasma for treating knee osteoarthritis: a one-year non-randomized retrospective comparative study. BMC Musculoskelet Disord. 2022, 23, Art. No: 23. DOI: 10.1186/s12891-021-04910-5.
11. Xie, X.; Zhang, C.; Tuan, R.S. Biology of platelet-rich plasma and its clinical application in cartilage repair. Arthritis Res. Ther. 2014, 16, Art. No: 204. DOI: 10.1186/ar4493.
12. Szwedowski, D.; Szczepanek, J.; Paczesny, Ł.; Zabrzyński, J.; Gagat, M.; Mobasheri, A.; Jeka, S. The Effect of Platelet-Rich Plasma on the Intra-Articular Microenvironment in Knee Osteoarthritis. Int. J. Mol. Sci. 2021, 22, Art. No: 5492. DOI: 10.3390/ijms22115492.
13. Khoshbin, A.; Leroux, T.; Wasserstein, D.; Marks, P.; Theodoropoulos, J.; Ogilvie-Harris, D.; Gandhi, R.; Takhar, K.; Lum, G.; Chahal, J. The Efficacy of Platelet-Rich Plasma in the Treatment of Symptomatic Knee Osteoarthritis: A Systematic Review With Quantitative Synthesis. Arthroscopy. 2013, 29, 2037–2048. DOI: 10.1016/j.arthro.2013.09.006.
14. Marmotti, A.; Rossi, R.; Castoldi, F,.; et al. PRP and articular cartilage: a clinical update. Biomed. Res. Int. 2015, 2015, Art. No: 542502. DOI: doi: 10.1155/2015/542502
15. Dohan Ehrenfest, D.M.; Andia, I.; Zumstein, M.A.; Chang-Qing, Z.; Pinto, N.R.; Bielecki, T. Classification of platelet concentrates (Platelet-Rich Plasma-PRP, Platelet-Rich Fibrin-PRF) for topical and infiltrative use in orthopedic and sports medicine: current consensus, clinical implications and perspectives. Muscles Ligaments Tendons J. 2014, 4, 3-9.
16. Filardo, G.; Kon, E.; Pereira Ruiz, M.; Vaccaro, F.; Guitaldi, R.; Di Martino, A.; et al. Platelet-rich plasma intra-articular injections for cartilage degeneration and osteoarthritis: single- versus double-spinning approach. Knee Surg. Sports Traumatol. Arthrosc. 2011, 20, 2082–2091. DOI: 10.1007/s00167-011-1837-x.
17. Braun, H.; Kim, H.; Chu, C.; Dragoo, J. The effect of platelet-rich plasma formulations and blood products on human synoviocytes. Am. J. Sports Med. 2014, 42, 1204–1210. DOI: 10.1177/0363546514525593.
18. Petrella, R.J.; Petrella, M. A prospective, randomized, double-blind, placebo controlled study to evaluate the efficacy of intraarticular hyaluronic acid for osteoarthritis of the knee. J. Rheumatol. 2006, 33, 951-956.
19. Cerza, F.; Carnì, S.; Carcangiu, A.; Di Vavo, I.; Schiavilla, V.; Pecora, A.; De Biasi, G.; Ciuffreda, M. Comparison between hyaluronic acid and platelet-rich plasma, intra-articular infiltration in the treatment of gonarthrosis. Am. J. Sports Med. 2012, 40, 2822-2827. DOI: 10.1177/0363546512461902.
20. Dold, A.P.; Zywiel, M.G.; Taylor, D.W.; Dwyer, T.; Theodoropoulos, J. Platelet-rich plasma in the management of articular cartilage pathology: a systematic review. Clin. J. Sport Med. 2014, 24, 31-43. DOI: 10.1097/01.jsm.0000432855.85143.e5.
21. Abhishek, A.; Doherty, M. Mechanisms of the placebo response in pain in osteoarthritis. Osteoarthr. Cartil. 2013, 21, 1229–1235. DOI: 10.1016/j.joca.2013.04.018.
22. Bennell, K.L.; Paterson, K.L.; Metcalf, B.R.; Duong, V.; Eyles, J.; Kasza, J.; Wang, Y.; Cicuttini, F.; Buchbinder, R.; Forbes, A.; Harris, A.; Yu, S.P.; Connell, D.; Linklater, J.; Wang, B.H.; Oo, W.M.; Hunter, D.J. Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis: The RESTORE Randomized Clinical Trial. JAMA. 2021, 326, 2021-2030. DOI: 10.1001/jama.2021.19415.
23. Filardo, G.; Previtali, D.; Napoli, F.; Candrian, C.; Zaffagnini, S.; Grassi, A. PRP Injections for the Treatment of Knee Osteoarthritis: A Meta-Analysis of Randomized Controlled Trials. Cartilage. 2021, 13, 364S-375S. DOI: 10.1177/1947603520931170.
24. Zhao, J.; Huang, H.; Liang, G.; Zeng, L.F.; Yang, W.; Liu, J. Effects and safety of the combination of platelet-rich plasma (PRP) and hyaluronic acid (HA) in the treatment of knee osteoarthritis: a systematic review and meta-analysis. BMC Musculoskelet Disord. 2020, 21, Art. No: 224. DOI: 10.1186/s12891-020-03262-w.
25. Raeissadat, S.A.; Ghazi Hosseini, P.; Bahrami, M.H.; Salman Roghani, R.; Fathi, M.; Gharooee Ahangar, A.; Darvish, M. The comparison effects of intra-articular injection of Platelet Rich Plasma (PRP), Plasma Rich in Growth Factor (PRGF), Hyaluronic Acid (HA), and ozone in knee osteoarthritis; a one year randomized clinical trial. BMC Musculoskelet Disord. 2021, 22, Art. No: 134. DOI: 10.1186/s12891-021-04017-x.
26. Joshi Jubert, N.; Rodríguez, L.; Reverté-Vinaixa, M.; Navarro, A. Platelet-rich plasma injections for advanced knee osteoarthritis: a prospective, randomized, double-blinded clinical trial. Orthop. J. Sports Med. 2017, 5, Art. No: 232596711668938. DOI: 10.1177/2325967116689386.
27. Phillips, M.; Bhandari, M.; Grant, J.; Bedi, A.; Trojian, T.; Johnson, A.; Schemitsch, E. A Systematic Review of Current Clinical Practice Guidelines on Intra-articular Hyaluronic Acid, Corticosteroid, and Platelet-Rich Plasma Injection for Knee Osteoarthritis: An International Perspective. Orthop. J. Sports Med. 2021, 9, Art. No: 23259671211030272. DOI: 10.1177/23259671211030272.
28. Shahid, M.; Kundra, R. Platelet-rich plasma (PRP) for knee disorders. EFORT Open Rev. 2017, 2, 28-34. DOI: 10.1302/2058-5241.2.160004.